IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2019

MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer. U.H. WEIDLE, F. BIRZELE, A. NOPORA (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 16: 99-119, 2019.
The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs. U.H. WEIDLE, A. EPP, F. BIRZELE, U. BRINKMANN (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 16: 1-19, 2019
Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas. O. ROMANIDOU, V. KOTOULA, G. FOUNTZILAS (Thessaloniki, Greece). Cancer Genomics Proteomics 15: 421-436, 2018.
Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors. U.H. WEIDLE, F. BIRZELE, G. TIEFENTHALER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 15: 225-238, 2018.
Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors. D. MORIS, I. NTANASIS-STATHOPOULOS, D.I. TSILIMIGRAS, M.A. ADAM, C.J. YANG, D. HARPOLE, S. THEOCHARIS (Durham, NC, USA; Athens, Greece). Cancer Genomics Proteomics 15: 153-163, 2018.
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics. S. HUANG, N. CAI, P. PENZUTI PACHECO, S. NARANDES, Y. WANG, W. XU (Winnipeg, Canada). Cancer Genomics Proteomics 15: 41-51, 2018.
The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets. U.H. WEIDLE, S. DICKOPF, C. HINTERMAIR, G. KOLLMORGEN, F. BIRZELE, U. BRINKMANN (Penzberg; Munich, Germany; Basel, Switzerland). Cancer Genomics Proteomics 15: 17-39, 2018.
Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, A. NOPORA (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 15: 1-15, 2018.
Impact of Mediterranean Diet on Cancer: Focused Literature Review. Y. BARAK, D. FRIDMAN (Dunedin; Wellington, New Zealand). Cancer Genomics Proteomics 14: 403-408, 2017.
Chemical Proteomic Approaches Targeting Cancer Stem Cells: A Review of Current Literature. H.J. JUNG (Asan, Republic of Korea). Cancer Genomics Proteomics 14: 315-327, 2017.
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises. N. GARMPIS, C. DAMASKOS, A. GARMPI, E. KALAMPOKAS, T. KALAMPOKAS, E. SPARTALIS, A. DASKALOPOULOU, S. VALSAMI, M. KONTOS, A. NONNI, K. KONTZOGLOU, D. PERREA, N. NIKITEAS, D. DIMITROULIS (Athens, Greece; Aberdeen, UK). Cancer Genomics Proteomics 14: 299-313, 2017.
The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2. C.M. PFEFFER, B.N. HO, A.T.K. SINGH (Kenosha, WI, USA). Cancer Genomics Proteomics 14: 293-298, 2017.
Cytokeratin 18-associated Histone 3 Modulation in Hepatocellular Carcinoma: A Mini Review. Y.-C.C. LAI, C.-C. CHENG, Y.-S. LAI, Y.-H. LIU (Kaohsiung; Changhua; Taichung; Hualien, Taiwan, ROC). Cancer Genomics Proteomics 14: 219-223, 2017
The Warburg Effect and Mass Spectrometry-based Proteomic Analysis. W. ZHOU, L.A. LIOTTA, E.F. PETRICOIN (Manassas, VA, USA). Cancer Genomics Proteomics 14: 211-218, 2017.
Long Non-coding RNAs and their Role in Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 14: 143-160, 2017.
Monochromosomal Hybrids and Chromosome Transfer: A Functional Approach for Gene Identification. R.P. KANDPAL, A.K. SANDHU, G. KAUR, G.P. KAUR, R.S. ATHWAL (Pomona, CA; Philadelphia, PA, USA). Cancer Genomics Proteomics 14: 93-101, 2017.
The Multiple Roles of Exosomes in Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 14: 1-15, 2017.
Clinical and Therapeutic Implications of Follistatin in Solid Tumours. L. SHI, J. RESAUL, S. OWEN, L. YE, W.G. JIANG (Yantai, Shandong, PR China; Cardiff, UK). Cancer Genomics Proteomics 13: 425-435, 2016.
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RUEGER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 13: 407-423, 2016.
Human Uterine Cervical Stromal Stem Cells (hUCESCs): Why and How they Exert their Antitumor Activity. J. SCHNEIDER, N. EIRÓ, R. PÉREZ-FERNÁNDEZ, A. MARTÍNEZ-ORDÓÑEZ, F. VIZOSO (Valladolid; Gijón; Santiago de Compostela, Spain). Cancer Genomics Proteomics 13: 331-337, 2016.
Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia. M. MEDINGER, C. LENGERKE, J. PASSWEG (Basel, Switzerland). Cancer Genomics Proteomics 13: 317-329, 2016.
Dissection of the Process of Brain Metastasis Reveals Targets and Mechanisms for Molecular-based Intervention. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany; Basel, Switzerland). Cancer Genomics Proteomics 13: 245-258, 2016.
The Significance of Proteomic Biomarkers in Male Breast Cancer. E. ZOGRAFOS, M. GAZOULI, G. TSANGARIS, E. MARINOS (Athens, Greece). Cancer Genomics Proteomics 13: 183-190, 2016.
Molecular Basis of Lung Tropism of Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany). Cancer Genomics Proteomics 13: 129-139, 2016.
Molecular Mechanisms of Bone Metastasis. U.H. WEIDLE, F. BIRZELE, G. KOLLMORGEN, R. RÜGER (Penzberg, Germany). Cancer Genomics Proteomics 13: 1-12, 2016.
Proteomics as a Guide for Personalized Adjuvant Chemotherapy in Patients with Early Breast Cancer. F. LUMACHI, G.B. CHIARA, L. FOLTRAN, S.M.M. BASSO (Padova; Pordenone, Italy). Cancer Genomics & Proteomics 12: 385-390, 2015.
Ensuring Sample Quality for Biomarker Discovery Studies – Use of ICT Tools to Trace Biosample Lifecycle. S. RIONDINO, P. FERRONI, A. SPILA, J. ALESSANDRONI, R. D’ALESSANDRO, V. FORMICA, D. DELLA-MORTE, R. PALMIROTTA, U. NANNI, M. ROSELLI, F. GUADAGNI (Rome, Italy). Cancer Genomics & Proteomics 12: 291-299, 2015.
The Blood–Brain Barrier Challenge for the Treatment of Brain Cancer, Secondary Brain Metastases, and Neurological Diseases. U.H. WEIDLE, J. NIEWÖHNER, G. TIEFENTHALER (Penzberg, Germany). Cancer Genomics & Proteomics 12: 167-177, 2015.
Caveolin-1, Breast Cancer and Ionizing Radiation. M. PUCCI, V. BRAVATÀ, G.I. FORTE, F.P. CAMMARATA, C. MESSA, M.C. GILARDI, L. MINAFRA (Cefalù; Milan; Monza, Italy). Cancer Genomics & Proteomics 12: 143-152, 2015.
TCR-MHC/Peptide Interaction: Prospects for new Anti-tumoral Agents. U.H. WEIDLE, G. GEORGES, G. TIEFENTHALER (Penzberg, Germany). Cancer Genomics & Proteomics 11: 267-277, 2014.
Tumor Interstitial Fluid: Proteomic determination as a Possible Source of Biomarkers. G. BARONZIO, G. PARMAR, M. BARONZIO, M. KISELEVSKY (Milan, Terni, Italy; Fort Langley, BC, Canada; Moscow, Russia). Cancer Genomics & Proteomics 11: 225-237, 2014.
Current State of mTOR Targeting in Human Breast Cancer. U. WAZIR, A. WAZIR, Z.S. KHANZADA, W.G. JIANG, A.K. SHARMA, K. MOKBEL (London; Cardiff, Wales, UK; Karachi, Pakistan). Cancer Genomics & Proteomics 11: 167-174, 2014.
Structure and Role of WASP and WAVe in Rho GTPase Signalling in Cancer. J. LANE, T. MARTIN, H.P. WEEKS, W.G. JIANG (Cardiff, UK). Cancer Genomics & Proteomics 11: 155-165, 2014.
Proteases as Activators for Cytotoxic Prodrugs in Antitumor Therapy. U.H. WEIDLE, G. TIEFENTHALER, G. GEORGES (Penzberg, Germany). Cancer Genomics & Proteomics 11: 267-79, 2014.
Isolation of Stem Cells Using Spheroids from Fresh Surgical Specimen: An Analytic Mini-Review. I. AVITAL, A. STOJADINOVIC, H. WANG, C. MANNION, W.-C. CHO, J. WANG, Y.-G MAN (Richmond, VA; Hackensack, NJ; Washington, DC, USA; Hangzhou; Hong Kong, P.R. China). Cancer Genomics & Proteomics 11: 57-65, 2014.
Prospects of Bacterial and Plant Protein-based Immunotoxins for Treatment of Cancer. U.H. WEIDLE, G. TIEFENTHALER, C. SCHILLER, E.H. WEISS, G. GEORGES, U. BRINKMANN (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 11: 25-38, 2014.
The Translational Potential for Target Validation and Therapy Using Intracellular Antibodies in Oncology.
U.H. WEIDLE, D. MAISEL, U. BRINKMANN, G. TIEFENTHALER (Penzberg, Germany). Cancer Genomics & Proteomics 10: 239-250, 2013.
Genomics and Proteomics Approaches for Biomarker Discovery in Sporadic Colorectal Cancer with Metastasis.
M. GONZÁLEZ-GONZÁLEZ, J. GARCIA GARCIA, J.A. ALCAZAR MONTERO, L.M. GONZÁLEZ FERNANDEZ, O. BENGOECHEA, O. BLANCO MUÑEZ, A. ORFAO, J.M. SAYAGUES, M. FUENTES (Salamanca, Spain). Cancer Genomics & Proteomics 10: 19-26, 2013.
The Intriguing Options of Multispecific Antibody Formats for Treatment of Cancer.
U.H. WEIDLE, G. TIEFENTHALER, E.H. WEISS, G. GEORGES, U. BRINKMANN (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 10: 1-18, 2013.
Cancer Metabolism: What we Can Learn from Proteomic Analysis by Mass Spectrometry.
W. ZHOU, L.A. LIOTTA, E.F. PETRICOIN (Manassas, VA, USA). Cancer Genomics & Proteomics 9: 373-382, 2012.
Genetically Engineered Fusion Proteins for Treatment of Cancer.
U.H. WEIDLE, B. SCHNEIDER, G. GEORGES, U. BRINKMANN (Penzberg, Germany). Cancer Genomics & Proteomics 9: 357-372, 2012.
Metastatic Biomarker Discovery Through Proteomics.
L.T. BRINTON, T.A. BRENTNALL, J.A. SMITH, K.A. KELLY (Charlottesville, VA; Seattle, WA, USA). Cancer Genomics & Proteomics 9: 345-356, 2012.
Metastasis from Oral Cancer: An Overview.
J. NOGUTI, C.F. DE MOURA, G.P. DE JESUS, V.H. DA SILVA, T.A. HOSSAKA, C.T. OSHIMA, D.A. RIBEIRO (Sao Paulo, Brazil). Cancer Genomics & Proteomics 9: 329-336, 2012.
Breast Cancer Metastasis.
O.J. SCULLY, B.-H. BAY, G. YIP, Y. YU (Singapore, Singapore). Cancer Genomics & Proteomics 9: 311-320, 2012.
Breast Cancer and Metastasis: On the Way Toward Individualized Therapy.
A.P. TRAPÉ, A.M. GONZALEZ-ANGULO (Houston, TX, USA). Cancer Genomics & Proteomics 9: 297-310, 2012.
Are we Missing the Target? – Cancer Stem Cells and Drug Resistance in Non-small Cell Lung Cancer.
S. GOTTSCHLING, P.A. SCHNABEL, F.J.F. HERTH, E. HERPEL (Heidelberg, Germany). Cancer Genomics & Proteomics 9: 275-286, 2012.
The Spectra Count Label-free Quantitation in Cancer Proteomics.
W. ZHOU, L.A. LIOTTA, E.F. PETRICOIN (Manassas, VA, USA). Cancer Genomics & Proteomics 9: 135-, 2012.
Fully Human Targeted Cytotoxic Fusion Proteins: New Anticancer Agents on the Horizon.
U.H. WEIDLE, G. GEORGES, U. BRINKMANN (Penzberg, Germany). Cancer Genomics & Proteomics 9: 119-134, 2012.
Dissection of Aberrant GPCR Signaling in Tumorigenesis – A Systems Biology Approach.
J. WU, N. XIE, X. ZHAO, E.C. NICE, C. HUANG (Chengdu, PR China; Clayton, VIC, Australia). Cancer Genomics & Proteomics 9: 37-50, 2012.
The Cancer Biomarker Osteopontin: Combination with Other Markers.
G.F. WEBER (Cincinnati, OH, USA). Cancer Genomics & Proteomics 8: 263-288, 2011.
Page: 1 2 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system